Capitalizing hope: the commercial development of umbilical cord blood stem cell banking

by: Paul Martin, Nik Brown, Andrew Turner

New Genetics and Society, Vol. 27, No. 2. (2008), pp. 127-143.

View FullText article

Reviews [Write a review of this article]

There are no reviews of this article

Find related articles from these CiteULike users

ricmilne, STS (group)

Find related articles with these CiteULike tags

hope, promise, stemcells

Abstract

The creation of commercial cord blood banks rests on the promise of stem cell based regenerative medicine and marks the capitalization of human tissues within a future-oriented regime of hope. This paper will present data from a survey of the international cord blood banking industry and will explore: (a) the way firms seek to commercialize cord blood as a new set of commodities; (b) the expectations and moral economy that are being constructed around this technology; and (c) how firms are acting as mediators of hope in what might be called a promissory bioeconomy.

@article{citeulike:2915474, abstract = {The creation of commercial cord blood banks rests on the promise of stem cell based regenerative medicine and marks the capitalization of human tissues within a future-oriented regime of hope. This paper will present data from a survey of the international cord blood banking industry and will explore: (a) the way firms seek to commercialize cord blood as a new set of commodities; (b) the expectations and moral economy that are being constructed around this technology; and (c) how firms are acting as mediators of hope in what might be called a promissory bioeconomy.}, author = {Martin, Paul and Brown, Nik and Turner, Andrew }, citeulike-article-id = {2915474}, doi = {10.1080/14636770802077074}, journal = {New Genetics and Society}, keywords = {hope, promise, stemcells}, number = {2}, pages = {127--143}, posted-at = {2008-06-22 20:20:33}, priority = {2}, publisher = {Routledge}, title = {Capitalizing hope: the commercial development of umbilical cord blood stem cell banking}, url = {http://dx.doi.org/10.1080/14636770802077074}, volume = {27}, year = {2008} }

RIS record

TY - JOUR ID - citeulike:2915474 L3 - citeulike-article-id:2915474 TI - Capitalizing hope: the commercial development of umbilical cord blood stem cell banking JF - New Genetics and Society VL - 27 IS - 2 SP - 127 EP - 143 PB - Routledge N2 - The creation of commercial cord blood banks rests on the promise of stem cell based regenerative medicine and marks the capitalization of human tissues within a future-oriented regime of hope. This paper will present data from a survey of the international cord blood banking industry and will explore: (a) the way firms seek to commercialize cord blood as a new set of commodities; (b) the expectations and moral economy that are being constructed around this technology; and (c) how firms are acting as mediators of hope in what might be called a promissory bioeconomy. KW - hope KW - promise KW - stemcells AU - Martin, Paul AU - Brown, Nik AU - Turner, Andrew PY - 2008/// UR - http://dx.doi.org/10.1080/14636770802077074 ER -

RIS BibTeX